Immunophenotyping and efficacy of low dose ATG in non-sensitized kidney recipients undergoing early steroid withdrawal: A randomized pilot study

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Grafals, Monica ^a,b   Smith, Brian ^c   Murakami, Naoka ^d   Trabucco, Agnes ^a   Hamill, Katherine ^a   Marangos, Erick ^a   Gilligan, Hannah ^a   Pomfret, Elizabeth A ^a   Pomposelli, James J ^a   Simpson, Mary A ^a   Azzi, Jamil ^c   Najafian, Nader ^c,e   Riella, Leonardo V ^c  

^a LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d BETH ISRAEL MEDICAL CENTER   (United States)

^e DEPARTMENT OF COLORECTAL SURGERY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LYMPHOCYTE ANTIBODY; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TACROLIMUS;

ADVERSE EFFECTS; ANALOGS AND DERIVATIVES; ANIMAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DOSE RESPONSE; DRUG EFFECTS; ECONOMICS; FEMALE; GRAFT REJECTION; HUMAN; IMMUNOLOGY; IMMUNOPHENOTYPING; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PILOT STUDY; RABBIT; RANDOMIZED CONTROLLED TRIAL; RISK; T LYMPHOCYTE; TIME; TREATMENT WITHDRAWAL;

ANIMALS; ANTILYMPHOCYTE SERUM; COST-BENEFIT ANALYSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOPHENOTYPING; IMMUNOSUPPRESSION; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; PILOT PROJECTS; RABBITS; RISK; STEROIDS; T-LYMPHOCYTES; TACROLIMUS; TIME FACTORS; WITHHOLDING TREATMENT;

EID: 84905833807     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0104408     Document Type: Article

References (31)

1. Halloran PF (2004) Immunosuppressive drugs for kidney transplantation. N Engl J Med 351: 2715-2729.
2. Matas AJ, Smith JM, Skeans MA, Lamb KE, Gustafson SK, et al. (2013) OPTN/SRTR 2011 Annual Data Report: kidney. Am J Transplant 13 Suppl 1: 11-46.
3. Meier-Kriesche HU, Li S, Gruessner RW, Fung JJ, Bustami RT, et al. (2006) Immunosuppression: evolution in practice and trends, 1994-2004. Am J Transplant 6: 1111-1131.
4. Kirk AD (2006) Induction immunosuppression. Transplantation 82: 593-602.
5. Thiyagarajan U, Ponnuswamy A, Bagul A (2013) Thymoglobulin and its use in renal transplantation: a review. American journal of nephrology 37: 586-601.
6. Meier-Kriesche HU, Arndorfer JA, Kaplan B (2002) Association of antibody induction with short- and long-term cause-specific mortality in renal transplant recipients. J Am Soc Nephrol 13: 769-772. (Pubitemid 34183944)
7. Opelz G, Naujokat C, Daniel V, Terness P, Dohler B (2006) Disassociation between risk of graft loss and risk of non-Hodgkin lymphoma with induction agents in renal transplant recipients. Transplantation 81: 1227-1233. (Pubitemid 43804539)
8. Thibaudin D, Alamartine E, Mariat C, Absi L, Berthoux F (2005) Long-term kinetic of T-lymphocyte subsets in kidney-transplant recipients: influence of anti-T-cell antibodies and association with posttransplant malignancies. Transplantation 80: 1514-1517. (Pubitemid 41803636)
9. Brennan D, Daller J, Lake K, Cibrik D, Del Castillo D, et al. (2006) Rabbit antithymocyte globulin versus basiliximab in renal transplantation. The New England journal of medicine 355: 1967-1977. (Pubitemid 44708016)
10. Goggins W, Pascual M, Powelson J, Magee C, Tolkoff-Rubin N, et al. (2003) A prospective, randomized, clinical trial of intraoperative versus postoperative Thymoglobulin in adult cadaveric renal transplant recipients. Transplantation 76: 798-802. (Pubitemid 37140222)
11. Hardinger K, Rasu R, Skelton R, Miller B, Brennan D (2010) Thymoglobulin induction dosing strategies in a low-risk kidney transplant population: three or four days? Journal of transplantation 2010: 957549.
12. Karen LH, Mark AS, Brent M, Jeffrey AL, Surendra S, et al. (2004) Five-Year Follow Up of Thymoglobulin Versus ATGAM Induction in Adult Renal Transplantation. Transplantation 78.
13. Lancaster GA, Dodd S, Williamson PR (2004) Design and analysis of pilot studies: recommendations for good practice. J Eval Clin Pract 10: 307-312. (Pubitemid 38823233)
14. D'Addio F, Boenisch O, Magee C, Yeung M, Yuan X, et al. (2013) Prolonged, low-dose anti-thymocyte globulin, combined with CTLA4-Ig, promotes engraftment in a stringent transplant model. PloS one 8.
15. Krystufkova E, Sekerkova A, Striz I, Brabcova I, Girmanova E, et al. (2012) Regulatory T cells in kidney transplant recipients: the effect of induction immunosuppression therapy. Nephrol Dial Transplant 27: 2576-2582.
16. Zheng XX, Sanchez-Fueyo A, Domenig C, Strom TB (2003) The balance of deletion and regulation in allograft tolerance. Immunol Rev 196: 75-84. (Pubitemid 37468105)
17. Fink PJ (2013) The biology of recent thymic emigrants. Annu Rev Immunol 31: 31-50.
18. Hardinger K, Brennan D, Klein C (2013) Selection of induction therapy in kidney transplantation. Transplant international: official journal of the European Society for Organ Transplantation 26: 662-672.
19. Brennan DC, Flavin K, Lowell JA, Howard TK, Shenoy S, et al. (1999) A randomized, double-blinded comparison of Thymoglobulin versus Atgam for induction immunosuppressive therapy in adult renal transplant recipients. Transplantation 67: 1011-1018. (Pubitemid 29200852)
20. Vincenti F, Schena FP, Paraskevas S, Hauser IA, Walker RG, et al. (2008) A randomized, multicenter study of steroid avoidance, early steroid withdrawal or standard steroid therapy in kidney transplant recipients. Am J Transplant 8: 307-316.
21. Gaber AO, Matas AJ, Henry ML, Brennan DC, Stevens RB, et al. (2012) Antithymocyte globulin induction in living donor renal transplant recipients: final report of the TAILOR registry. Transplantation 94: 331-337.
22. Rizzari MD, Suszynski TM, Gillingham KJ, Dunn TB, Ibrahim HN, et al. (2012) Ten-year outcome after rapid discontinuation of prednisone in adult primary kidney transplantation. Clin J Am Soc Nephrol 7: 494-503.
23. Wong W, Agrawal N, Pascual M, Anderson DC, Hirsch HH, et al. (2006) Comparison of two dosages of thymoglobulin used as a short-course for induction in kidney transplantation. Transpl Int 19: 629-635.
24. Woodle ES, First MR, Pirsch J, Shihab F, Gaber AO, et al. (2008) A prospective, randomized, double-blind, placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long-term, low-dose corticosteroid therapy. Ann Surg 248: 564-577.
25. Hardinger K, Rhee S, Buchanan P, Koch M, Miller B, et al. (2008) A prospective, randomized, double-blinded comparison of thymoglobulin versus Atgam for induction immunosuppressive therapy: 10-year results. Transplantation 86: 947-952.
26. Kirk AD, Hale DA, Mannon RB, Kleiner DE, Hoffmann SC, et al. (2003) Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (CAMPATH-1H). Transplantation 76: 120-129. (Pubitemid 36877125)
27. Todeschini M, Cortinovis M, Perico N, Poli F, Innocente A, et al. (2013) In kidney transplant patients, alemtuzumab but not basiliximab/low-dose rabbit anti-thymocyte globulin induces B cell depletion and regeneration, which associates with a high incidence of de novo donor-specific anti-HLA antibody development. J Immunol 191: 2818-2828.
28. Farney AC, Doares W, Rogers J, Singh R, Hartmann E, et al. (2009) A randomized trial of alemtuzumab versus antithymocyte globulin induction in renal and pancreas transplantation. Transplantation 88: 810-819.
29. Hanaway M, Woodle E, Mulgaonkar S, Peddi V, Kaufman D, et al. (2011) Alemtuzumab induction in renal transplantation. The New England journal of medicine 364: 1909-1919.
30. Gurkan S, Luan Y, Dhillon N, Allam S, Montague T, et al. (2010) Immune reconstitution following rabbit antithymocyte globulin. American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 10: 2132-2141.
31. Tchao N, Turka L (2012) Lymphodepletion and homeostatic proliferation: implications for transplantation. American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 12: 1079-1090.